2.1. Antibiosis

Figure 2. Number of published papers between the period of 1988–2017 addressing biocontrol of mycotoxigenic fungi

with and without considering the effect on mycotoxins.

62 Mycotoxins - Impact and Management Strategies

Production of a wide range of antibiotics, enzymes and other antifungal compounds which contribute to adverse impacts on plant pathogen are characteristic features of different fungal BCAs such as Trichoderma spp. and Clonostachys spp. [8, 11, 24, 33]; bacterial BCAs such as Bacillus spp., Pseudomonas spp., Streptomyces spp. and Lactobacillus spp. [19, 20, 34, 35]; and yeast BCAs such as Cryptococcus spp., Kluyveromyces spp. and Saccharomyces spp. [10, 36]. All these BCAs have an arsenal of metabolites targeting different structures of the pathogen which thereafter curtails the growth or kills the pathogen.
